Ukr.Biochem.J. 2023; Volume 95, Issue 3, May-Jun, pp. 42-48

doi: https://doi.org/10.15407/ubj95.03.042

Extragenital and infectious factors may provoke miscarriage

T. G. Gutor1, N. F. Timchenko1*, O. I. Matsyura2

1Department of Social Medicine, Economics and Organization of Health Care,
Danylo Halytsky Lviv National Medical University, Lviv, Ukraine;
2Department of Pediatrics №2, Danylo Halytsky Lviv National
Medical University, Lviv, Ukraine;
*e-mail: timchenkonataliaf@ukr.net

Received: 08 May 2023; Revised: 05 June 2023;
Accepted: 11 June 2023; Available on-line: 11 July 2023

Adverse reproductive outcome before term is a polyetiological pathology associated with demographic crisis. Some adverse outcomes include perinatal and neonatal infant mortality, major morbidity and mortality of children under two years, violation of psychomotor and physical development, cognitive disturbances and disability of children under age five. Finding ways to solve these issues remain a priority. The research involved two female groups. The experimental group included 403 women after the involuntary termination of pregnancy, premature birth or in case of threat of miscarriage; the control group included 402 women with physiological course of pregnancy and parturient with full-term pregnancy. The study required the application of systemic approaches and methods including structural, logical, medical and statistical analyses. The survey revealed more than 20 infectious risk factors and more than 70 factors of extragenital origin. The most significant infectious pathologies included COVID-19 (36.23 ± 2.29% and 14.93 ± 1.78%), herpes type 1 (5.96 ± 1.18% and 1.0 ± 0.50%), toxoplasmosis (4.22 ± 1.0% and 1.0 ± 0.50%) and chlamydial infection (4.22 ± 1.0% 0.50 ± 0.35%) in the experimental and control groups, respectively (P < 0.01). The most significant extragenital pathologies involved autoimmune thyroiditis (8.68 ± 1.40% and 0.75 ± 0.43%), type 1 diabetes mellitus (2.23 ± 0.74% and 0%) and allergic rhinitis/sinusitis (3.97 ± 0.97% and 0.50 ± 0.35%) in the experimental and control groups, respectively (P < 0.01). Obtained results will be used in the development of a personified risk-oriented model for the prevention of preterm pregnancy loss.

Keywords: , , , ,


References:

  1. Tietzmann MR, Teichmann PDV, Vilanova CS, Goldani MZ, Silva CHD. Risk Factors for Neonatal Mortality in Preterm Newborns in The Extreme South of Brazil. Sci Rep. 2020;10(1):7252. PubMed, PubMedCentral, CrossRef
  2. Torchin H, Ancel PY, Jarreau PH, Goffinet F. Epidemiology of preterm birth: Prevalence, recent trends, short- and long-term outcomes. J Gynecol Obstet Biol Reprod (Paris). 2015;44(8):723-731. (In French). PubMed, CrossRef
  3. Torchin H, Ancel PY. Epidemiology and risk factors of preterm birth. J Gynecol Obstet Biol Reprod (Paris). 2016;45(10):1213-1230. (In French).  PubMed, CrossRef
  4. Quenby S, Gallos ID, Dhillon-Smith RK, Podesek M, Stephenson MD, Fisher J, Brosens JJ, Brewin J, Ramhorst R, Lucas ES, McCoy RC, Anderson R, Daher S, Regan L, Al-Memar M, Bourne T, MacIntyre DA, Rai R, Christiansen OB, Sugiura-Ogasawara M, Odendaal J, Devall AJ, Bennett PR, Petrou S, Coomarasamy A. Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss. Lancet. 2021;397(10285):1658-1667. PubMed, CrossRef
  5. Rossen LM, Ahrens KA, Branum AM. Trends in Risk of Pregnancy Loss Among US Women, 1990-2011. Paediatr Perinat Epidemiol. 2018;32(1):19-29. PubMed, PubMedCentral, CrossRef
  6. Timchenko NF, Gutor TG. Dynamics of miscarriage among the female population of fertile age in Ukraine and in Lviv region in 2014–2021. Acta Medica Leopoliensia. 2022;28(3-4):72-86. CrossRef
  7. Lorthe E, Torchin H, Delorme P, Ancel P-Y, Marchand-Martin L, Foix-L’Hélias L, Benhammou V, Gire C, d’Ercole C, Winer N, Sentilhes L, Subtil D, Goffinet F, Kayem G. Preterm premature rupture of membranes at 22-25 weeks’ gestation: perinatal and 2-year outcomes within a national population-based study (EPIPAGE-2). Am J Obstet Gynecol. 2018;219(3):298.e1-298.e14. PubMed, CrossRef
  8. Tang J, Chen R, Yu Y, Bao W, Tiemeier H, Rodney A, Zhu X, Li M, Huang D, Zhao Q. Associations of pre-pregnancy impaired fasting glucose and body mass index among pregnant women without pre-existing diabetes with offspring being large for gestational age and preterm birth: a cohort study in China. BMJ Open Diabetes Res Care. 2021;9(1):e001641. PubMed, PubMedCentral, CrossRef
  9. Schjenken JE, Green ES, Overduin TS, Mah CY, Russell DL, Robertson SA. Endocrine Disruptor Compounds-A Cause of Impaired Immune Tolerance Driving Inflammatory Disorders of Pregnancy? Front Endocrinol (Lausanne). 2021;12:607539. PubMed, PubMedCentral, CrossRef
  10. Tang W, Mao J, Li KT, Walker JS, Chou R, Fu R, Chen W, Darville T, Klausner J, Tucker JD. Pregnancy and fertility-related adverse outcomes associated with Chlamydia trachomatis infection: a global systematic review and meta-analysis. Sex Transm Infect. 2020;96(5):322-329. PubMed, PubMedCentral, CrossRef
  11. Jaiswal N, Puri M, Agarwal K, Singh S, Yadav R, Tiwary N, Tayal P, Vats B. COVID-19 as an independent risk factor for subclinical placental dysfunction. Eur J Obstet Gynecol Reprod Biol. 2021;259:7-11. PubMed, PubMedCentral, CrossRef
  12. Bouachba A, Allias F, Nadaud B, Massardier J, Mekki Y, Bouscambert Duchamp M, de la Fournière B, Huissoud C, Trecourt A, Collardeau-Frachon S. Placental lesions and SARS-Cov-2 infection: Diffuse placenta damage associated to poor fetal outcome. Placenta. 2021;112:97-104. PubMed, PubMedCentral, CrossRef

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.